The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes

European Journal of Human Genetics

Volumn 21, Issue 7, 2013, Pages 703-707

  Fears, Robin ^a   Ter Meulen, Volker ^a  

^a German Academy of Sciences Leopoldina   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSUMER; DIRECT TO CONSUMER GENETIC TESTING; GENETIC MARKER; GENETIC SCREENING; GERMANY; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; NUTRIGENOMICS; PHARMACOGENETICS; PRENATAL SCREENING; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL;

EUROPE; FEMALE; GENETIC DISEASES, INBORN; GENETIC TESTING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; PUBLIC HEALTH; QUALITY CONTROL;

EID: 84879412963     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.238     Document Type: Article

References (37)

1. Janssens ACJW, Ioannidis JPA, van Duijn CM, Little J, Khoury MJ: For the GRIPS Group: strengthening the reporting of genetic risk prediction: the GRIPS statement. Eur J Hum Genet 2011; 19: 833-836.
2. Patch C, Sequeiros J, Cornel MC: Genetic horoscopes: is it all in the genes? Points for regulatory control of direct-to-consumer genetic testing. Eur J Hum Genet 2009; 17: 857-859.
3. Heald B, Edelman E, Eng C: Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet 2012; 20: 547-551.
4. European Society of Human Genetics. Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes. Eur J Hum Genet 2010; 18: 1-3.
5. Human Genetics Commission. A common framework of principles for direct-to-consumer genetic testing. Report, 2010. Available from http://www.hgc.gov.uk.
6. American Medical Association. Genetic testing should be conducted by qualified health professionals. Letter to FDA, 2011. Available from http://www.ama-assn.org/resources.doc.washington/consumer-genetic-testing- letter.pdf.
7. Leopoldina academy, acatech and Berlin-Brandenburg academy of Arts and Sciences. Predictive genetic diagnosis as an instrument of disease prevention. Report, 2010. Available from http://www.leopoldina.org.
8. Borry P, van Hellemondt RE, Sprumont D et ah Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet 2012; 20: 715-721.
9. Caulfield T, Ries NM, Shuman C, Wilson B: Direct-to-consumer genetic testing: good, bad or benign? Clin Genet 2010; 77: 101-105
10. EASAC. European public health and innovation policy for infectious disease: the view from EASAC. Report, 2011. Available from http://www.easac.eu.
11. Fears R, van der Meer JWM, ter Meulen V: The changing burden of infectious disease in Europe. Sci Transl Med 2011; 3, 103cm30 1-4
12. EASAC. Realising European potential in synthetic biology: scientific opportunities and good governance. Report, 2010. Available from http://www.easac.eu
13. EASAC-European Commission Joint Research Centre. Impact of engineered nanoma-terials on health: considerations for benefit-risk assessment. Report, 2011. Available from http://www.easac.eu.
14. FEAM. Opportunities and challenges for reforming the EL) Clinical Trials directive: an academic perspective. Statement, 2010. Available from. http://www.feam.eu.com.
15. FEAM. Statement on the EL) Physical Agents Directive. Statement, 2011. Available from http://www.feam.eu.com.
16. Fears R, Hoschl C: European mental health policy: opportunities for science and innovation, challenges for implementation. Eur J Publ Health 2011; 21: 550-551
17. EASAC-FEAM. Direct-to-consumer genetic testing for health-related purposes in the EL): the view from the academies of science and medicine. Report, 2012. Available from http://www.easac.euand.
18. http://www.feam.eu.com.
19. DeJongA, DondorpWJ, Frints SGM, de Die-Smulders CEM, de Wert GMWR: Advances in prenatal screening: the ethical dimension. Nature Rev Genet 2011; 12: 657-663.
20. Vijverberg SJH, Pieters T, Cornel MC: Ethical and social issues in pharmacogenomics testing. Curr Pharm Design 2010; 16: 99-106.
21. Howard HC, Avard A, Borry P: Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms? Eur J Hum Genet 2011; 19: 1122-1126.
22. Wright CF, Hall A, Zimmern RL: Regulating direct-to-consumer genetic tests: what is all the fuss about? Genet Med 2011; 13: 295-300.
23. Nuffield Council on Bioethics. Medical profiling and online medicine: the ethics of 'personalised healthcare' in a consumer age. Report, 2010. Available from http://www.nuffield.co.uk.
24. Kopits IM, Chen C, Roberts JS, Uhlmann W, Green RC: Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility. Genet Test Molec Biomarkers 2011; 15: 871-875.
25. NIH. Genetic Testing Registry. Announcement, 2012. Available from http://oba. od.nih.gov/GTR/gtr-intro.html.
26. Mattocks CJ, Morris MA, Matthijs G et al. A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet 2010;18: 1276-1288.
27. Botkin JR, Teutsch SM, Kaye CI et ah Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med 2010; 12: 228-235.
28. Roberts J, Christensen K, Green R: Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics. Clin Genet 2011; 80: 407-414.
29. Van El CG, Cornel MC: on behalf of the ESHG Public and Professional Policy Committee: genetic testing and common disorders in a public health framework. Eur J Hum Genet 2011; 19: 377-381.
30. Brett GR, Metcalfe SA, Amor DJ, Halliday JL: An exploration of genetic health professionals' experience with direct-to-consumer genetic testing in their clinical practice. Eur J Hum Genet 2012; 20: 825-830
31. American Society of Human Genetics. Researchers shed light on implications and assessment of using direct-to-consumer and clinical genetic testing in disease risk assessment. Statement, 2010. Available from http://www.ashg.org/pdf/PR-DTC- Clinical-110510.pdf.
32. Skirton H, Lewis C, Kent A, Coviello DA: The members of Eurogentest Unit 6 and ESHG Education Committee: genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe. Eur J Hum Genet 2010; 18: 972-977.
33. Do CB, Tung JY, Dorfman E et al: Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet 2011; 7: e1002141
34. Foundation for Genomics and Population Health. Next steps in the sequence. The implications of whole genome sequencing for health in the UK. Report, 2011. Available from http://www.phgfoundation.org.
35. Li R, Li Y, Zheng H et al: Building the sequence map of the human pan-genome. Nature Biotech 2010; 28: 57-63.
36. World Health Organization. Grand challenges in genomics for public health in developing countries. Statement, 2011. Available from http://www.who.int/ rpc/grand-challenges.pdf.
37. Grimaldi KA, Look MP, Scioli GA, Clavero JC, Marinos S, Tagaris T: Personal genetics: regulatory framework in Europe from a service provider's perspective. Eur J Hum Genet 2011; 19: 382-388.